Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-11-17

Clinical Trial Update: Purified Anthocyanins Supplementation in Type 2 Diabetes Mellitus [EARLY_Phase 1]

View source ↗

Summary

This entry reports the completion of an early-phase clinical trial assessing purified anthocyanin supplementation in individuals with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Purified Anthocyanins (anthocyanin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Diabetes Mellitus,Type 2 | EARLY_Phase 1 | Status: COMPLETED